Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000347899 | SCV000337853 | benign | not specified | 2015-12-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002502125 | SCV002812346 | likely benign | Rubinstein-Taybi syndrome due to CREBBP mutations; Menke-Hennekam syndrome 1 | 2021-09-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002518956 | SCV003250895 | benign | Rubinstein-Taybi syndrome | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003909970 | SCV004726320 | likely benign | CREBBP-related disorder | 2021-07-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |